The in vitro effects of dehydroepiandrosterone on chondrocyte metabolism

Osteoarthritis and Cartilage

Volumn 14, Issue 3, 2006, Pages 238-249

  Sun, J S ^a,b   Wu, C X ^c   Tsuang, Y H ^a   Chen, L T ^d   Sheu, Shiow Yunn ^c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Healthbanks Biotechnology Corporation Ltd   (Taiwan)

Author keywords

Arthritis; Chondrocyte; Dehydroepiandrosterone; Metalloproteinase; Tissue inhibitor of metalloproteinase 1

Indexed keywords

AGAROSE; COLLAGEN; COLLAGENASE 3; CYCLOOXYGENASE 2; GLYCOSAMINOGLYCAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MATRIX PROTEIN; PRASTERONE; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ARTICLE; BACTERIAL ARTHRITIS; CARTILAGE CELL; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; IN VITRO STUDY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RAT STRAIN;

ANIMALS; CARTILAGE, ARTICULAR; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2; DEHYDROEPIANDROSTERONE; DINOPROSTONE; GENE EXPRESSION; GLYCOSAMINOGLYCANS; HYDROXYPROLINE; INTERLEUKIN-6; MATRIX METALLOPROTEINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33644676057     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2005.09.012     Document Type: Article

References (57)

1. T. Pincus G.G. Koch T. Sokka J. Lefkowith F. Wolfe J.M. Jordan et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee Arthritis Rheum 44 2001 1587-1598
2. P. Ravaud L. Moulinier B. Giraudeau X. Ayral C. Guerin E. Noel et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: Results of a multicenter, randomized, controlled trial Arthritis Rheum 42 1999 475-482
3. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update Arthritis Rheum 43 2000 1905-1915
4. A. Pendleton N. Arden M. Dougados M. Doherty B. Bannwarth J.W. Bijlsma et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 59 2000 936-944
5. M. Yoshioka C. Shimizu F.L. Harwood R.D. Coutts D.Y. Amiel Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee Osteoarthritis Cartilage 6 1998 1-9
6. P.J. Hornsby DHEA: A biologist's perspective J Am Geriatr Soc 45 1997 1395-1401
7. P. Alexandersen J. Haarbo C. Christiansen The relationship of natural androgen to coronary heart disease in males: A review Atherosclerosis 125 1996 1-14
8. B. Zumoff J. Levin R.S. Rosenfeld M. Markham G.W. Strain D.K. Fukushima et al. Abnormal 24-hour mean plasma concentrations of dehydroepiandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer Cancer Res 41 1981 3360-3363
9. D.L. Coleman R.W. Schweitzer E.H. Leiter Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants in aged normal mice Diabetes 33 1984 26-32
10. E. Barrett-Connor A. Ferrara Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and non-insulin dependent diabetes in postmenopausal women: The Rancho Bernardo Study J Clin Endocrinol Metab 81 1996 59-64
11. R.R. Watson A. Hulls M. Araghi-Niknam S. Chung Dehydroepiandrosterone (DHEA) supplementation to prevent symptoms of aging Drugs Aging 9 1996 274-291
12. P.H. Dessein B.I. Joffe A.E. Stanwix Z. Moomal Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis Arthritis Res 3 2001 183-188
13. M. Cutolo Sex hormone adjuvant therapy in rheumatoid arthritis Rheum Dis Clin North Am 26 2000 881-895
14. P.J. Williams R.H. Jones T.W. Rademacher Reduction in the incidence and severity of collagen-induced arthritis in DBA/1 mice, using exogenous dehydroepiandrosterone Arthritis Rheum 40 1997 907-911
15. K.S. Lee K.Y. Oh B.C. Kim Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture J Dermatol Sci 23 2000 103-110
16. H. Jo J.S. Park E.M. Kim M.Y. Jung S.H. Lee S.C. Seong et al. The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes Osteoarthritis Cartilage 11 2003 585-594
17. M.M. Hartert G. Martin P. Devel G.D. Dupont J.Y. Reginster Y. Henrotin Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes Inflamm Res 52 2003 111-118
18. M. Cao A.W. Larson C. Niyibizi K. Kavalkovich H.I. Georgescu C.F. Rizzo et al. Nitric oxide inhibits the synthesis of type 2 collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target Biochem J 324 1997 305-310
19. M.M. Knight D.A. Lee D.L. Bader The influence of elaborated pericellular matrix on the deformation of isolated articular chondrocytes cultured in agarose Biochim Biophys Acta 1405 1998 67-77
20. R.W. Farndale D.J. Buttle A.J. Barrett Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue Biochem Biophys Acta 883 1986 173-177
21. M.R. Neidert E.S. Lee T.R. Oegema R.T. Tranquillo Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents Biomaterials 23 2002 3717-3731
22. P. Das D.J. Schurman R.L. Smith Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear J Orthop Res 15 1997 87-93
23. K.M. Ririe R.P. Rasmussen C.T. Wittwer Product differentiation by analysis of DNA melting curves during the polymerase chain reaction Anal Biochem 245 1997 154-160
24. R.M. Clancy A.R. Amin S.B. Abramson The role of nitric oxide in inflammation and immunity Arthritis Rheum 41 1998 1141-1151
25. R.H. Straub M. Cutolo Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role [review] Arthritis Rheum 44 2001 493-507
26. M. Cutolo B. Seriolo B. Villaggio C. Pizzorni C. Craviotto A. Sulli Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis [review] Ann N Y Acad Sci 966 2002 131-142
27. G.J. Dulos W.M. Bagchus Androgens indirectly accelerate thymocyte apoptosis Int Immunopharmacol 1 2001 321-328
28. H.L. Bradlow J. Murphy J.J. Byrne Immunological properties of dehydroepiandrosterone, its conjugates, and metabolites Ann N Y Acad Sci 876 1999 91-101
29. F. Svec J.R. Porter The actions of exogenous dehydroepiandrosterone in experimental animals and humans Proc Soc Exp Biol Med 218 1998 174-191
30. T.T. Chowdhury D.L. Bader D.A. Lee Dynamic compression inhibits the synthesis of nitric oxide and PGE2by IL-1β stimulated chondrocytes cultured in agarose constructs BBRC 285 2001 1168-1174
31. M.R. Williams S. Ling T. Dawood K. Hashimura A. Dai H. Li et al. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs J Clin Endocrinol Metab 87 2002 176-181
32. B. Rais B. Comin J. Puigjaner J.L. Brandes E. Creppy D. Saboureau et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlichs tumor cells through inhibition of the pentose cycle FEBS Lett 456 1999 113-118
33. M. Di Monaco A. Pizzini V. Gatto L. Leonardi M. Gallo E. Brignardello et al. Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells Br J Cancer 75 1997 589-592
34. E. Gilad H.R. Wong B. Zingarelli L. Virag M. Oconnor A.L. Salzman et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFκB activation FASEB J 12 1998 685-693
35. J.E. Shaffer B.J. Han W.H. Chern F.W. Lee Lack of tolerance to a 24-hour infusion of s-nitroso n-acetylpenicillamine (SNAP) in conscious rabbits J Pharmacol Exp Ther 260 1990 286-293
36. R. Mayne M.S. Vail P.M. Mayne E.J. Miller Changes in type of collagen synthesized as clones of chick chondrocytes grow and eventually lose division capacity Proc Natl Acad Sci USA 73 1976 1674-1678
37. F. Binette D.P. McQuaid D.R. Haudenschild P.C. Yaeger J.M. McPherson R. Tubo Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro J Orthop Res 16 1998 207-216
38. R. Visse H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry Circ Res 92 2003 827-839
39. T. Sadowski J. Steinmeyer Effects of non-steroidal anti-inflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by bovine articular chondrocytes Osteoarthritis Cartilage 9 2001 407-415
40. S. Chubinskaya K.E. Kuettner A.A. Cole Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints Lab Invest 79 1999 1669-1999
41. G. Bluteau T. Conrozier P. Mathieu E. Vignon D. Herbage F. Mallein-Gerin Matrix metalloproteinase-1, -3,-13 and aggrecanases-1 and -2 are differentially expressed in experimental OA Biochim Biophys Acta 1526 2001 147-158
42. T. Aigner A. Zien A. Gehrsitz P.M. Gebhard L. McKenna Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology Arthritis Rheum 44 2001 2777-2789
43. D.D. Dean J. Martel-Pelletier J.P. Pelletier D.S. Howell J.F. Woessner Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage J Clin Invest 84 1989 678-685
44. G. Bluteau J. Gouttenoire T. Conrozier P. Mathieu E. Vignon M. Richard et al. Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section Biorheology 39 2002 247-258
45. K. Takahashi R.S. Goomer F. Harwood T. Kubo Y. Hirasawa D. Amiel The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of OA Osteoarthritis Cartilage 7 1997 182-190
46. J. Martel-Pelletier M. Zafarullah S. Kodama J.P. Pelletier In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage J Rheumatol 18 1991 S80-S84
47. T. Sadowski J. Steinmyer Modulation of the synthesis and activation of matrix metalloproteinases in IL-1-treated chondrocytes by antirheumatic drugs Ann N Y Acad Sci 878 1999 612-614
48. E. Nedelec A. Abid C. Cipolletta N. Presle B. Terlain P. Netter et al. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: Lack of contribution to loss of cartilage anabolism Biochem Pharmacol 61 2001 965-978
49. M. Araghi-Niknam B. Liang Z. Zhang S.K. Ardestani R.R. Watson Modulation of immune dysfunction during murine leukemia retrovirus infection of old mice by dehydroepiandrosterone sulfate (DHEAS) Immunology 90 1997 344-349
50. D. Ben-Nathan D.A. Padgett R.M. Loria Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity J Med Microbiol 48 1999 425-431
51. R.H. Straub L. Konecna S. Hrach G. Rothe M. Kreutz J. Scholmerich et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence J Clin Endocrinol Metab 83 1998 2012-2017
52. M.E. Poynter R.A. Daynes Peroxisome proliferator activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in again J Biol Chem 273 1998 32833-32841
53. R. Dashtaki A.R. Whorton T.M. Murphy P. Chitano W. Reed T.P. Kennedy Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation J Pharmacol Exp Ther 285 1998 876-883
54. M. Schmidt M. Kreutz G. Loffler J. Scholmerich R.H. Straub Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages J Endocrinol 164 2000 161-169
55. Y. Geng J. Valbracht M. Lotz Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes J Clin Invest 98 1996 2425-2430
56. M.P. Vincenti C.I. Coon C.E. Brinckerhoff Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta stimulated synovial fibroblasts Arthritis Rheum 41 1998 1987-1994
57. J.A. Mengshol M.P. Vincenti C.I. Coon A. Barchowsky C.E. Brinckerhoff Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor [kappa]B: Differential regulation of collagenase 1 and collagenase 3 Arthritis Rheum 43 2000 801-811